The widespread acceptance among the oncology community at large of Cytoreductive Surgery and HIPEC as a potentially curative treatment for Peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients..
The widespread acceptance among the oncology community at large of Cytoreductive Surgery and HIPEC as a potentially curative treatment for Peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients.